* Mesa Laboratories Inc MLAB.OQ MLAB.O is expected
to show a
fall in quarterly revenue when it reports results
* The Lakewood Colorado-based company is expected to report
a
7.0% decrease in revenue to $54.649 million from $58.75 million
a year ago, according to the mean estimate from 2 analysts,
based on LSEG data.
* Refinitiv's mean analyst estimate for Mesa Laboratories
Inc is
for earnings of 16 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Mesa
Laboratories
Inc is $139, above its last closing price of $90.34.
This summary was machine generated November 3 at 16:09 GMT. All
figures in US dollars unless otherwise stated